Incorporating Equity–Efficiency Interactions in Cost-Effectiveness Analysis—Three Approaches Applied to Breast Cancer Control

Author： Baeten Stefan A. Baltussen Rob M. P. M. Uyl-de Groot Carin A. Bridges John Niessen Louis W.

Publisher： Blackwell Publishing

ISSN： 1098-3015

Source： Value in Health, Vol.13, Iss.5, 2010-08, pp. : 573-579

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Weighting Must Wait: Incorporating Equity Concerns into Cost-Effectiveness Analysis May Take Longer than Expected

By Wailoo Allan

PharmacoEconomics, Vol. 27, Iss. 12, 2009-12 ,pp. : 983-989

Adis International

Access to resources Recommend Favorite

Cost-effectiveness analysis of papillary thyroid cancer surveillance

Cancer, Vol. 121, Iss. 23, 2015-12 ,pp. : 4132-4140

Blackwell Publishing

Access to resources Recommend Favorite

Information Technology Facilitates Cost-Effectiveness Analysis in Developing Countries: An Observational Study of Breast Cancer Chemotherapy in Taiwan

By >

PharmacoEconomics, Vol. 27, Iss. 11, 2009-11 ,pp. : 947-961

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Exemestane Compared with Megestrol in Advanced Breast Cancer: A Model for Europe and Australia

By Lindgren P.

PharmacoEconomics, Vol. 20, Iss. 2, 2002-02 ,pp. : 101-108

Adis International

Access to resources Recommend Favorite

Review of cost-effectiveness analyses in hormonal therapies in advanced breast cancer

By Benedict Ágnes Brown Ruth E

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 11, 2005-09 ,pp. : 1789-1801

Informa Healthcare

Access to resources Recommend Favorite